Device treatment of heart failure.
Background: The incidence of heart failure (HF) is rapidly increasing, introducing a significant burden and challenges in clinical practice. Non-pharmacological cardiac device therapy has been established as an essential component of optimal HF management, particularly for the prevention of sudden c...
| Published in: | Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi Vol. 65; no. 1; pp. 26 - 37 |
|---|---|
| Main Author: | |
| Format: | pictorial tables/charts Journal Article |
| Published: |
Korean Medical Association
Jan2022
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154913010&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 154913010 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 19758456 B9M7 jtl: Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi issn: 19758456 maglogo: N pubinfo: dt: Jan2022 vid: 65 iid: 1 pid: 64891 pub: Korean Medical Association place: , <Blank> artinfo: ui: 154913010 154913010 154913010 10.5124/jkma.2022.65.1.26 154913010 ppf: 26 ppct: 11 formats: fmt: @attributes: type: P tig: atl: Device treatment of heart failure. aug: au: Seung-Jung Park affil: Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea sug: subj: Heart Failure Therapy Heart Failure Prognosis Cardiac Resynchronization Therapy Equipment and Supplies Death, Sudden, Cardiac Prevention and Control Cardiac Resynchronization Therapy Defibrillators, Implantable Methods Ventricular Function, Left Physiology Quality of Life Heart Block Therapy Ventricular Dysfunction Physiopathology Bundle of HIS Bundle-Branch Block Heart Conduction System Cardiac Pacing, Artificial Biometrics Methods Patient Safety Cardiac Patients Cardiac Contractility Modulation Systems Prostheses and Implants ab: Background: The incidence of heart failure (HF) is rapidly increasing, introducing a significant burden and challenges in clinical practice. Non-pharmacological cardiac device therapy has been established as an essential component of optimal HF management, particularly for the prevention of sudden cardiac death and the improvement of HF symptoms, left ventricular (LV) systolic function, quality of life, and eventually survival. Current Concepts: Cardiac resynchronization therapy (CRT) can correct atrioventricular or inter/intraventricular dyssynchrony, thereby improving LV systolic function. Recently, the concept of CRT is being expanded, including His bundle (HB), HB-optimized LV, left bundle branch (LBB), and LBB optimized LV pacing CRTs. Newly introduced CRT approaches by stimulating the cardiac conduction system are expected to correct dyssynchrony better and consequently exhibit better CRT outcomes than the conventional biventricular pacing CRT. The current versions of implantable cardioverter-defibrillators (ICDs) or CRT devices can continuously monitor multiple bio-signals. CRT/ICD can calculate a single index by combining these multiple bio-signal data for early detection of HF aggravation. Recently, subcutaneous and transvenous ICDs showed comparable safety and efficacy in HF patients. In drug-refractory HF patients without LV dyssynchrony, cardiac contractility modulation therapy provides some promising results. Discussion and Conclusion: Recent technological advancements have improved the efficacy and safety of cardiac device therapy. Therefore, cardiac device therapy should be used more actively to manage HF patients better. pubtype: Academic Journal doctype: pictorial tables/charts Journal Article ougenre: Article language: Korean refInfo: holdings: @attributes: islocal: N |
|---|